about
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophyInherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 casesMajor clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.Eruptive lingual papillitis with household transmission: a prospective clinical studyThe scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literature.Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response.Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone.308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study.SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells.Pigmentary sequelae of AIDS-related cutaneous Kaposi sarcoma: successful treatment by Q-switched 755-nm alexandrite and 532-nm Nd:YAG lasers.In vivo reflectance confocal microscopy of the skin: a noninvasive means of assessing body cystine accumulation in infantile cystinosis.Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up.Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial.Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases.Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial.[Skin microbiota and atopic dermatitis: toward new therapeutic options?].Endothelial Cells Promote Pigmentation through Endothelin Receptor B Activation.Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS).Fractionated bipolar radiofrequency and bipolar radiofrequency potentiated by infrared light for treating striae: A prospective randomized, comparative trial with objective evaluation.Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.Candidate mechanisms for capecitabine-related hand-foot syndrome.High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressivenessSecretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.Epidermolysis bullosa simplex with muscular dystrophy.Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.Reflectance confocal microscopy of mucosal pigmented macules: a review of 56 cases including 10 macular melanomas.Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata.A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies.Drug rash with eosinophilia and systemic symptoms due to telaprevir.Centrifugal hypomelanosis: a new clinical phenotype of Malassezia infection.Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.[Wells Syndrome in children and atopy: Retrospective study of 11 cases and review of the literature].Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments.[Juvenile dermatomyositis in the Nice area: a retrospective study 1991-2001]Use of high-definition optical coherent tomography (HD-OCT) for imaging of melanoma.A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
P50
Q24562137-124406B3-8A41-4C21-A7F4-B8D6C1DFD480Q26740232-4DB9E49B-B013-4857-9E5C-C7C4361ED823Q27852303-E6EE0F7A-77A7-43E4-8534-6BE21DFC26FCQ28247988-A3D8F82C-61B6-4ACE-BDEB-90CEFD0FB7E3Q30244561-52B8EAFC-77A6-4F0E-968D-B0D00E50A223Q30837806-5BBF6DE5-746C-4D54-BFE4-9CD7EAFFB861Q31114137-C3186964-ADF1-4A74-ABC7-B8C8FF42FDFFQ33434118-F670AD60-4288-435B-B3A0-9A7B88D74B4FQ33546636-79826E77-1A4F-4F68-93E7-EB9EBB7FF384Q33688529-EC874545-A750-4C5E-82C2-8339B9214872Q33964853-A0137A57-2F5A-4AC2-8762-7D10A78AE7AEQ34036712-8E9A6AD5-158B-40DE-9B47-360953678FF2Q34483418-514D4E03-45C2-46E6-A1D7-E5E177D8DA81Q35123506-E68BAC74-09D4-4149-B99B-0DC24999BBC2Q35203542-3EE0D4D6-5374-45C9-A3EB-84BF456B487BQ35485972-8B3045EC-113E-401A-94BF-80DE9C4EE20AQ35567717-EC874656-4405-4885-AD05-2A92587E19FDQ35573415-42283236-0D9E-4809-92F0-A1467D20BA75Q35755885-6A870ACD-EC5D-402F-8B9F-E9C17BF0E9A0Q35966700-29FB5D1B-2A11-4659-955E-62D40D77DE38Q35971777-1E4BEF3B-C847-49B7-94FD-FEB9D1395B37Q36215925-26E8139B-59FE-4CCB-A184-6E4BFB6096ADQ36716705-06E193C7-F7EE-43AF-9148-D899A098140FQ36792721-D780F620-82BD-415D-BF9F-7A5C37B18B5FQ37045507-8653FC5B-DD00-4936-9947-A47D086E457FQ37589120-99E0359E-6EF2-45EB-89CD-498B6474DECCQ37743807-39E8B00F-75A9-4F01-9B56-FBF0A7A8BAFDQ37997833-9D9699B5-327B-4EB9-9769-BD4A7FD59CE7Q38173007-5933AD07-39D2-4A7F-9119-594899F9493FQ38429515-AFA60260-82EB-48FA-8258-1886FAF026FCQ39197355-1C387B57-41B5-4E5F-8DB4-334941BC1022Q39328334-25FBF865-6541-45B5-98F7-3124B24BBEACQ39843638-98EDAC85-F35E-4D4C-BCC3-F15330D33FEEQ40531910-6F2D0F49-FB3E-4775-BFB3-8824DE422CB8Q40973506-E2889B18-3069-4FCF-A93A-4F7369E291C5Q41352786-DA33FD19-AA3D-41F5-A475-61BC5B5EE5F2Q41905577-E5D55E7F-1B6A-4D81-A7AF-577529BB5BC8Q41916636-FD91362A-7D3A-4AF3-BCDE-5E216488689DQ42438273-BA8CD548-6A7C-4B77-BF4E-2314061CC50AQ42667247-7BC0C1BB-3F57-4078-A1E0-C3DB9E422BCF
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jean-Philippe Lacour
@ast
Jean-Philippe Lacour
@en
Jean-Philippe Lacour
@es
Jean-Philippe Lacour
@nl
Jean-Philippe Lacour
@sl
type
label
Jean-Philippe Lacour
@ast
Jean-Philippe Lacour
@en
Jean-Philippe Lacour
@es
Jean-Philippe Lacour
@nl
Jean-Philippe Lacour
@sl
prefLabel
Jean-Philippe Lacour
@ast
Jean-Philippe Lacour
@en
Jean-Philippe Lacour
@es
Jean-Philippe Lacour
@nl
Jean-Philippe Lacour
@sl
P106
P21
P213
0000 0000 0471 1839
P214
1818147967348184200002
P31
P496
0000-0001-7663-2053
P7859
viaf-1818147967348184200002